Nora Therapeutics, Inc. Report issue

For profit Phase 2
Founded: Palo Alto CA United States (2007)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2013
NCT01864356
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

nt100 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Habitual (Phase 2)

Abortion, Spontaneous (Phase 2)

Fetal Death (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1